This story originally ran on Jan. 30.

Waters this week reported Q4 2011 revenues of $521 million, up eight percent from $484 million in Q4 2010, and beating Wall Street estimates of $516.9 million.

For the quarter, the company posted a profit of $137.1 million, or $1.51 per share. On a non-GAAP basis, EPS was $1.56, beating analyst estimates of $1.50 per share. In the year-ago period the company had a profit of $126.6 million, or $1.36 per share, and $1.38 per share on a non-GAAP basis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.